Article

State of Science Summit- Lung Cancer: Chaired by Sarah Goldberg, MD, MPH & Roy S. Herbst, MD, PhD

State of Science Summit- Lung Cancer: Chaired by Sarah Goldberg, MD, MPH & Roy S. Herbst, MD, PhD

State of Science Summit- Lung Cancer: Chaired by Sarah Goldberg, MD, MPH & Roy S. Herbst, MD, PhD

Speakers

  • Scott Gettinger, MD | Yale Cancer Center Smilow Cancer Center Hospital
  • Anne Chiang, MD, PhD | Yale Cancer Center Smilow Cancer Center Hospital
  • Justin Blasberg, MD, MPH, FACS | Yale Cancer Center Smilow Cancer Center Hospital
  • Henry S. Park, MD, MPH | Yale Cancer Center Smilow Cancer Center Hospital
  • Michael Cohenuram, MD | Yale Cancer Center Smilow Cancer Center Hospital
  • So Yeon Kim, MD | Yale Cancer Center Smilow Cancer Center Hospital

Topics

  • Recent Updates in the Treatment of Metastatic NSCLC
  • EGFR: Adjuvant to Metastatic
  • Managing SCLC
  • Novel Agents and Emerging Targets in Lung Cancer
  • Case discussion: Early-Stage Lung Cancer

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
David R. Spigel, MD, chief scientific officer, Sarah Cannon Research Institute
Video 6 - "Reflex Testing for Patients with Suspected Lung Cancer"
Video 5 "Biomarker Testing in Early-Stage NSCLC"
Suresh Ramalingam, MD, and Chandler Park, MD
Suresh S. Ramalingam, MD, FACP, FASCO, professor, Department of Hematology and Medical Oncology, Roberto C. Goizueta Distinguished Chair for Cancer Research, Emory University School of Medicine, executive director, Winship Cancer Institute of Emory University, associate vice president, cancer, Woodruff Health Sciences Center
Byoung Chol Cho, MD, PhD, professor, internal medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Ben Levy, MD, and Yan Leyfman, MD
BDTX-1535 – A MasterKey EGFR Inhibitor Targeting Classical, Non-Classical, and the C797S Resistance Mutation To Address The Evolved Landscape Of EGFR Mutant NSCLC